Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Hold” by Analysts

Phreesia, Inc. (NYSE:PHR) has earned an average recommendation of “Hold” from the nineteen ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $16.6471.

Several equities analysts recently commented on the company. Canaccord Genuity Group dropped their price objective on Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, May 28th. Truist Financial raised their target price on Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a research report on Thursday, May 28th. Stephens lowered their target price on Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 31st. KeyCorp dropped their price target on Phreesia from $15.00 to $12.00 and set an “overweight” rating on the stock in a research report on Monday, April 13th. Finally, Needham & Company LLC dropped their price target on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, March 31st.

Phreesia Stock Performance

Shares of PHR stock opened at $10.73 on Monday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market cap of $663.28 million, a price-to-earnings ratio of 71.54 and a beta of 0.87. Phreesia has a 52 week low of $7.77 and a 52 week high of $32.76. The firm’s 50-day simple moving average is $9.75 and its two-hundred day simple moving average is $11.33.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The firm had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. During the same period in the prior year, the firm earned ($0.07) EPS. The company’s revenue was up 12.9% compared to the same quarter last year. As a group, equities analysts forecast that Phreesia will post 0.39 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. EverSource Wealth Advisors LLC boosted its position in Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after purchasing an additional 3,001 shares during the period. Van ECK Associates Corp raised its position in shares of Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after purchasing an additional 1,102 shares during the period. New York State Teachers Retirement System bought a new stake in shares of Phreesia in the first quarter valued at approximately $44,000. Rockefeller Capital Management L.P. raised its position in shares of Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after purchasing an additional 2,149 shares during the period. Finally, KBC Group NV lifted its stake in shares of Phreesia by 83.4% during the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock valued at $58,000 after buying an additional 1,568 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.